Jack Hsu is a Hematology physician affiliated with University of Florida Health. OpenAlex indexes 132 publications with 3,202 citations (h-index 28); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-392-3000Registry record last updated 21 Mar 2008.
Clinical trials
- Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
35%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor24.6%Valacyclovir100%Part D≥20 patientsShort-acting sulfonamides6%Sulfamethoxazole-Trimethoprim100%Part D<11 patients+ 1 more class in this area
Nervous system
30.9%Opioid Agonist13.9%Oxycodone Hcl100%Part D≥14 patientsGabapentinoids13.2%Gabapentin71%Pregabalin29%Part D<11 patients+ 1 more class in this area
Cancer & immunology
15.5%Thalidomide Analog6.6%Lenalidomide100%Part D<11 patientsKinase inhibitor5.4%Imatinib Mesylate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2023 per NIH RePORTER. The latest:
- Core Clinical Consortium for Blood and Marrow Transplant Clinical Trials Network
University of Florida
FY2023$155,470UG1HL069301
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of <scp>ABO</scp> mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
American Journal of Hematology
2023 - Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
Leukemia & lymphoma/Leukemia and lymphoma
2020 - The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era
Biology of Blood and Marrow Transplantation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida Health
Jamie Conti, MD
University of Florida Health
Westley Reeves, MD
University of Florida Health
Joanne Lagmay, MD
University of Florida Health
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”